Ohara N, Matsuoka M, Nomaguchi H, Naito M, Yamada T
Nagasaki University School of Dentistry, Sakamoto 1-7-1, 852-8588, Nagasaki, Japan.
Vaccine. 2001 Feb 28;19(15-16):1906-10. doi: 10.1016/s0264-410x(00)00439-4.
The components of Ag85 (Ag85A, Ag85B, and Ag85C) are putative protective antigen candidates against mycobacterial infection. A recombinant Mycobacterium bovis Bacillus Calmette-Guérin (rBCG) over-producing Ag85A, Ag85B, and MPB51 (rBCG/BA51) was constructed. rBCG/BA51 could secrete these antigens at levels more than five times higher than parental BCG. Immunization of C57BL/6 and BALB/c mice with this rBCG reduced the multiplication of Mycobacterium leprae in the foot pads of both strains of mice. The inhibition by rBCG/BA51 was more evident than that by parental BCG.